Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 090874
Company: MYLAN INSTITUTIONAL

Products on ANDA 090874

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
ISOSULFAN BLUE	ISOSULFAN BLUE	1%	INJECTABLE;INJECTION	Prescription	AP	No	Yes

Approval Date(s) and History, Letters, Labels, Reviews for ANDA 090874

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
07/20/2010	ORIG-1	Approval			Letter (PDF)	Label is not available on this site.	https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2010/090874s000ltr.pdf

Therapeutic Equivalents for ANDA 090874

ISOSULFAN BLUE

INJECTABLE;INJECTION; 1%
TE Code = AP

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
ISOSULFAN BLUE	ISOSULFAN BLUE	1%	INJECTABLE;INJECTION	Prescription	No	AP	211869	FRESENIUS KABI USA
ISOSULFAN BLUE	ISOSULFAN BLUE	1%	INJECTABLE;INJECTION	Prescription	No	AP	213130	MEITHEAL
ISOSULFAN BLUE	ISOSULFAN BLUE	1%	INJECTABLE;INJECTION	Prescription	No	AP	216090	MSN
ISOSULFAN BLUE	ISOSULFAN BLUE	1%	INJECTABLE;INJECTION	Prescription	No	AP	090874	MYLAN INSTITUTIONAL